Colgate-Palmolive Company $CL Shares Sold by DJE Kapital AG

DJE Kapital AG cut its stake in Colgate-Palmolive Company (NYSE:CL) by 68.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 66,871 shares of the company’s stock after selling 142,723 shares during the quarter. DJE Kapital AG’s holdings in Colgate-Palmolive were worth $5,341,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of CL. CBIZ Investment Advisory Services LLC grew its holdings in shares of Colgate-Palmolive by 86.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after purchasing an additional 150 shares during the period. Jessup Wealth Management Inc purchased a new position in shares of Colgate-Palmolive during the 4th quarter worth $26,000. Maseco LLP purchased a new position in shares of Colgate-Palmolive during the 4th quarter worth $27,000. Global Wealth Strategies & Associates grew its holdings in shares of Colgate-Palmolive by 300.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after purchasing an additional 300 shares during the period. Finally, Camelot Portfolios LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter worth $32,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $89.48 on Friday. The business has a 50-day moving average of $86.77 and a 200 day moving average of $86.23. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $99.33. The stock has a market capitalization of $71.60 billion, a price-to-earnings ratio of 34.82, a price-to-earnings-growth ratio of 4.74 and a beta of 0.33. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. During the same period last year, the business posted $0.91 EPS. Colgate-Palmolive’s revenue for the quarter was up 8.4% on a year-over-year basis. As a group, sell-side analysts forecast that Colgate-Palmolive Company will post 3.81 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is 82.49%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on CL shares. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating for the company in a report on Wednesday, April 8th. Barclays increased their price target on Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a report on Tuesday, May 5th. Royal Bank Of Canada restated an “outperform” rating and set a $102.00 price target on shares of Colgate-Palmolive in a research note on Monday, May 4th. Wall Street Zen cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Sunday, March 29th. Finally, Rothschild & Co Redburn set a $100.00 price target on Colgate-Palmolive and gave the stock a “buy” rating in a research note on Tuesday, April 21st. Twelve equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average price target of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.